HighMark Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
HighMark Wealth Management's NVS Position: Q3 2026 in Review
HighMark Wealth Management opened a new position in Novartis (NVS) in Q3 2026: 95 shares worth $13.5K. The stake represents ﹤0.01% of the portfolio and ranks #303 among its holdings. This is a return to the name: HighMark Wealth Management previously reported a position in NVS as recently as Q3 2025.
HighMark Wealth Management first reported a position in NVS in Q4 2019 and has held it in 22 quarters since. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- HighMark Wealth Management held 95 shares of Novartis worth $13.5K as of Q3 2026.
- Novartis was a new HighMark Wealth Management position in Q3 2026.
- Novartis made up ﹤0.01% of HighMark Wealth Management's portfolio in Q3 2026, its #303 holding.
- HighMark Wealth Management first reported a position in Novartis in Q4 2019 and has held it in 22 quarters since.
- 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on HighMark Wealth Management's 13F filing for Q3 2026, filed 17 Nov 2026.